Robert M. Plenge - EVP, Chief Research Officer at Bristol Myers Squibb Co

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Research Officer
Stock Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert M. Plenge since 12/12/2024

Holdings reported by Robert M. Plenge for Bristol Myers Squibb Co

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Market Share Units 23.4K $1.24M $52.99 Mar 10, 2025 Direct Common Stock, $0.10 par value
Common Stock, $0.10 par value 15.8K $1M $63.11 Mar 10, 2025 Direct
Common Stock, $0.10 par value 11.3K $609K $53.79 Mar 10, 2024 Direct
Common Stock, $0.10 par value 2.1K $132K $63.11 Mar 10, 2025 BMS Savings and Investment Program
Common Stock, $0.10 par value 1.66K $89.1K $53.79 Mar 10, 2024 BMS Savings and Investment Program
Common Stock, $0.10 par value 200 $12.6K $63.11 Mar 10, 2025 Family Trust
Common Stock, $0.10 par value 200 $10.8K $53.79 Mar 10, 2024 Family Trust
Performance Shares 35.1K Mar 10, 2025 Direct Common Stock, $0.10 par value

Transactions reported by Robert M. Plenge for Bristol Myers Squibb Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.